TNF and rheumatoid arthritis: In accordance with reduced CXCL16 expression in the joint following successful anti-TNF therapy, serum levels of CXCL16 were also decreased after anti-TNF treatment in two cohorts of 23 and 44 RA patients, respectively (97, 98).